Pantoprazole Sodium Granule, Delayed Release
Product Images NDC 59651-671

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 59651-671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Pantoprazole Fig1)

FDA Label Image

Fig2 (Pantoprazole Fig2)

This text provides detailed instructions and information about the medication Pantoprazole Sodium in delayed-release oral suspension form. It includes guidance on administration methods, storage conditions, dosing instructions, and precautions. The text also mentions the importance of keeping medications out of reach of children and provides a website for printing medication guides.*

FDA Label Image

Str (Pantoprazole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.